Kyle Carver

Chief Financial Officer

Chief Financial Officer at Evommune, Inc., filing insider transactions on 2026-07-08.

Total Purchases

$13K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-07-08

Last: 2026-07-08

Companies

Evommune, Inc.

Other Reporting Insiders at Evommune, Inc.

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-07-08	EVMN	Purchase	1,000	$13.26	$13K	60.3K	SEC ↗